Cognitive-behavioural treatment for amphetamine-type stimulants use — evidence summary

Summary of the evidence

Unknown effectiveness

A  systematic review (Harada et al 2018) of two small RCTs (n=210) addressing the efficacy of cognitive-behavioural treatment (CBT) for people with amphetamine-type stimulants (ATS) use disorder found that there were insufficient data for conclusive assessment of CBT in the treatment of ATS use disorders (SMD -0.28, 95% CI -0.69 to 0.14).


Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option:
cognitive-behavioural treatment
Desired outcome(s):
reduce substance use
Specific substance or pattern of use:

Explore all resources in the Best practice portal

Best practice evidence summaries

Collaborations and partnerships in best practice

logo of the cochrane collaboration  grade logo   grade logo  Health Evidence Network, WHO Europe